Skip to content
Catalyst

PapersPMID:41124892

The effects of Oligo-Fucoidan on muscle function in community-dwelling older adults: A double-blind, randomized, placebo-controlled trial.

Archives of gerontology and geriatrics2026The record ↗

  1. Finding, very limited evidenceraisesHandgrip strength (hand dynamometer)

What moved

1 findingHow to read these marks →
  • “MANOVA of percent changes across six outcomes indicated significant overall group differences, driven primarily by greater improvements in grip strength in the Oligo-Fucoidan supplementation group compared with placebo.”
    Study
    RCT
    Duration
    3 months
    Population
    Community-dwelling adults aged 60 years or older; three-arm trial (Oligo-Fucoidan alone, Oligo-Fucoidan with BCAA and vitamin D, placebo), the claim is for the Oligo-Fucoidan-alone arm against placebo

Study record

Design
randomised controlled trial
Species
human
Population
Community-dwelling older adults aged 60 years or more; low-molecular-weight Oligo-Fucoidan, with or without branched-chain amino acids and vitamin D, versus placebo (abstract only)
Participants
60
Comparator
placebo
Duration
84 days
Endpoints measured
7